Pharma firms free to set prices for half of medicines in Pakistan

The Drug Regulatory Authority of Pakistan (DRAP) has announced that pharmaceutical companies are now allowed to set prices for 50% of the medicines sold in the country.

In a recent TV interview, DRAP CEO Dr. Obaidullah explained that the government continues to control prices for life-saving and necessary drugs. However, around 50 percent of medicines are now under a free-market system, allowing pharmaceutical companies to set prices on their own.

According to Dr. Obaidullah, a detailed survey of 100 commonly used medicines has already been completed. He said the government is prepared to take immediate action if any instructions are issued regarding price control or market review. He also shared that a second phase of the survey will begin soon, focusing on medicines that have recently become more expensive in the market.

Meanwhile, authorities are trying to strike a balance between ensuring affordability for the public and allowing companies to operate under market conditions. The objective is to make sure essential medicines remain within reach of patients while keeping the pharmaceutical sector functional and competitive.

The DRAP chief added that monitoring efforts are being strengthened to stop unjustified price hikes. He stressed that keeping essential medicines affordable is the top priority of the government. At the same time, deregulation is aimed at improving the availability of other medicines and encouraging investment in the pharmaceutical industry. This policy comes as people across the country continue to face rising healthcare costs, making strict oversight and timely intervention important to protect patients and support the health sector.